Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.
- 15 December 1993
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (24), 11473-11477
- https://doi.org/10.1073/pnas.90.24.11473
Abstract
Leishmania parasites cause a spectrum of diseases that afflict the populations of 86 countries in the world. The parasites can survive within the lysosomal compartments of the host's macrophages, unless those macrophages are appropriately activated. Despite the fact that protective immunity can be induced by vaccination with crude parasite preparations, little progress has been made toward a defined vaccine for humans. In this study the gene encoding the Leishmania surface proteinase gp63 was cloned and expressed as a cytoplasmic protein in a bacille Calmette-Guérin (BCG) vaccine strain. BALB/c and CBA/J mice were inoculated with a single dose of recombinant BCG and challenged with infective Leishmania major or Leishmania mexicana promastigotes. Significant protection was observed in both mouse strains against L. mexicana and in CBA/J against L. major, whereas only a delay in L. major growth was seen in BALB/c mice. Recombinant BCG also engendered a strong protective response against challenge with amastigotes of L. mexicana, demonstrating that the induced immune response recognized the intracellular form of the parasite. The results support the view that recombinant BCG expressing gp63 may prove a useful vaccine for inducing protective cell-mediated immune responses to Leishmania species causing American cutaneous leishmaniasis.Keywords
This publication has 29 references indexed in Scilit:
- The lysosomal gp63‐related protein in Leishmania mexicana amastigotes is a soluble metalloproteinase with an acidic pH optimumFEBS Letters, 1993
- Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infectionResearch in Immunology, 1991
- The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages.The Journal of Experimental Medicine, 1991
- The major surface glycoprotein (GP63) is present in both life stages of LeishmaniaMolecular and Biochemical Parasitology, 1990
- The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stageMolecular and Biochemical Parasitology, 1989
- Immunotherapy of Localized, Intermediate, and Diffuse Forms of American Cutaneous LeishmaniasisThe Journal of Infectious Diseases, 1989
- T-Cell Responses and Immunity to Experimental Infection with Leishmania MajorAnnual Review of Immunology, 1989
- Functional heterogeneity of CD4+ T cells in leishmaniasisImmunology Today, 1989
- Genes encoding the major surface glycoprotein in Leishmania are tandemly linked at a single chromosomal locus and are constitutively transcribedMolecular and Biochemical Parasitology, 1989
- IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN LOCALISED CUTANEOUS LEISHMANIASISThe Lancet, 1987